CASSAVA SCIENCES INC.
25.52
08-November-24 09:59:48
15 minutes delayed
Stocks
+0.18
+0.71%
Today's range
24.75 - 26.05
ISIN
N/A
Source
NASDAQ
-
21 Jun 2021 15:10:00 By Nasdaq GlobeNewswire
-
21 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the Raymond James 2021 Human Health Innovation Conference
17 Jun 2021 15:01:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of Directors
14 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease
24 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Initiation of Cognition Maintenance Study in Alzheimer’s disease
10 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference
27 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum
26 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
21 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Full-year 2020 Financial Results and Business Highlights
23 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
09 Mar 2021 08:00:00 By Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the H.C. Wainwright Global Life Sciences Conference
08 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences to Present at SVB Leerink Global Healthcare Conference
23 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
22 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces Closing of $200 Million Registered Direct Offering
12 Feb 2021 16:08:17 By Nasdaq GlobeNewswire
-
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
10 Feb 2021 05:15:06 By Nasdaq GlobeNewswire
-
08 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
02 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
04 Jan 2021 07:30:00 By Nasdaq GlobeNewswire